Allergy Therapeutics plc
AGYTF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 36.9% | -7.4% | -18.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.7% | 53.9% | 55.8% | 68% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -53.5% | -55.7% | -58.9% | -10.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -72.9% | -72.9% | -72.3% | -18.9% |
| EPS Diluted | -0.008 | -0.011 | -0.038 | -0.012 |
| % Growth | 21.5% | 71.5% | -213.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |